Evidence map›Paper›PMID 31267096›Full record

ArticleNature chemical biology2019

Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy, Claire Whitworth, Emelyne Diers, Nicole Trainor, David Zollman, Steffen Steurer, Jale Karolyi-Oezguer, Carina Riedmueller and 27 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Recent Advances in PROTACs for Drug Targeted Protein Research.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 2 institutions in 2 countries.

William FarnabyDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0001-8610-932X
Manfred KoeglBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Michael J RoyDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0003-0198-9108
Claire WhitworthDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0003-3174-7652
Emelyne DiersDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0001-5951-7918
Nicole TrainorDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
David ZollmanDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Steffen SteurerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Jale Karolyi-OezguerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Carina RiedmuellerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Teresa GmaschitzBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Johannes WachterBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Christian DankBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Michael GalantBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Bernadette SharpsBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Klaus RumpelBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Elisabeth TraxlerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Thomas GerstbergerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Renate SchnitzerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Oliver PetermannBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Peter GrebBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Harald WeinstablBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Gerd BaderBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Andreas ZoephelBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Alexander Weiss-PuxbaumBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Katharina Ehrenhöfer-WölferBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.ORCID http://orcid.org/0000-0002-8893-6131
Simon WöhrleBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.ORCID http://orcid.org/0000-0002-2478-7333
Guido BoehmeltBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Joerg RinnenthalBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Heribert ArnhofBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Nicola WiechensCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.
Meng-Ying WuCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.
Tom Owen-HughesCentre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, UK.
Peter EttmayerBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.ORCID http://orcid.org/0000-0002-8422-2625
Mark PearsonBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Darryl B McConnellBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria. darryl.mcconnell@boehringer-ingelheim.com.ORCID http://orcid.org/0000-0002-2537-3458
Alessio CiulliDivision of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK. a.ciulli@dundee.ac.uk.ORCID http://orcid.org/0000-0002-8654-1670
Boehringer Ingelheim (Austria) · ATUniversity of Dundee · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this article originally published, several lines of text in the last paragraph of the right column on page 1 of the PDF were transposed into the bottom paragraph of the left column. The affected text of the left column should read "The ATP-dependent activities of the BAF (SWI/SNF) chromatin remodeling complexes affect the positioning of nucleosomes on DNA and thereby many cellular processes related to chromatin structure, including transcription, DNA repair and decatenation of chromosomes during mitosis

Identifiers

PMID31267096
OpenAlexW2954106333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.